Fungal Infections Are Not Associated with Increased Mortality in COVID-19 Patients Admitted to Intensive Care Unit (ICU)

被引:2
作者
Ainsworth, James [1 ]
Sewell, Peter [1 ]
Eggert, Sabine [1 ]
Morris, Keith [2 ]
Pillai, Suresh [1 ]
机构
[1] Morriston Hosp, Ed Major Intens Care Unit, Swansea, Wales
[2] Cardiff Metropolitan Univ, Cardiff, Wales
关键词
BACTERIAL;
D O I
10.1155/2023/4037915
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction. Fungal infection is a cause of increased morbidity and mortality in intensive care patients. Critically unwell patients are at increased risk of developing invasive fungal infections. COVID-19 patients in the intensive care unit (ICU) may be at a particularly high risk. +e primary aim of this study was to establish the incidence of secondary fungal infections in patients admitted to the ICU with COVID-19. Secondary aims were to investigate factors that may contribute to an increased risk of fungal infections and to calculate the mortality between fungal and nonfungal groups. Methods. We undertook a retrospective observational study in a tertiary ICU in Wales, United Kingdom. 174 patients admitted with COVID-19 infection from March 2020 until May 2021 were included. Data were collected through a retrospective review of patient's clinical notes and microbiology investigation results obtained from the online clinical portal. Results. 81/174 (47%) COVID-19 patients developed fungal infections, 93% of which were Candida species, including Candida albicans (88%), and 6% had an Aspergillus infection. Age and smoking history did not appear to be contributing factors. +e nonfungal group had a significantlyhigher body mass index (33 +/- 8 vs. 31 +/- 7, p. 0.01). +e ICU length of stay (23 (1-116) vs. 8 (1-60), p < 0.001), hospital length of stay (30 (3-183) vs. 15 (1-174) +/- 7, p < 0.001), steroid days (10 (1-116) vs. 4 (0-28), p. 0.02), and ventilation days (18 (0-120) vs. 2 (0-55), p < 0.001) were significantly higher in the fungal group. The mortality rate in both groups was similar (51% vs. 52%). +e Kaplan-Meier survival analysis showed that the fungal group survived more than the nonfungal group (log rank (Mantel-Cox), p < 0.001). Conclusion. Secondary fungal infections are common in COVID-19 patients admitted to the ICU. Longer treatment with corticosteroids, increased length of hospital and ICU stay, and greater length of mechanical ventilation significantlyincrease the risk of fungal infections. Fungal infection, however, was not associated with an increase in mortality.
引用
收藏
页数:6
相关论文
共 23 条
  • [1] Coinfections with Bacteria, Fungi, and Respiratory Viruses in Patients with SARS-CoV-2: A Systematic Review and Meta-Analysis
    Alhumaid, Saad
    Al Mutair, Abbas
    Al Alawi, Zainab
    Alshawi, Abeer M.
    Alomran, Salamah A.
    Almuhanna, Mohammed S.
    Almuslim, Anwar A.
    Bu Shafia, Ahmed H.
    Alotaibi, Abdullah M.
    Ahmed, Gasmelseed Y.
    Rabaan, Ali A.
    Al-Tawfiq, Jaffar A.
    Al-Omari, Awad
    [J]. PATHOGENS, 2021, 10 (07):
  • [2] Incidence of Bacterial and Fungal Secondary Infections in COVID-19 Patients Admitted to the ICU
    Alshrefy, Afnan J.
    Alwohaibi, Rawaa N.
    Alhazzaa, Shahad A.
    Almaimoni, Reema A.
    AlMusailet, Latifah, I
    AlQahtani, Shaya Y.
    Alshahrani, Mohammed S.
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 7475 - 7485
  • [3] Fungal Infections in COVID-19 Intensive Care Patients
    Coskun, Aysenur Sumer
    Durmaz, Senay Ozturk
    [J]. POLISH JOURNAL OF MICROBIOLOGY, 2021, 70 (03) : 395 - 400
  • [4] Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation
    De Bruyn, Astrid
    Verellen, Stijn
    Bruckers, Liesbeth
    Geebelen, Laurien
    Callebaut, Ina
    De Pauw, Ilse
    Stessel, Bjorn
    Dubois, Jasperina
    [J]. BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [5] EFFECTS OF CIGARETTE-SMOKE ON EPITHELIAL-CELLS OF THE RESPIRATORY-TRACT
    DYE, JA
    ADLER, KB
    [J]. THORAX, 1994, 49 (08) : 825 - 834
  • [6] Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study
    Falcone, Marco
    Tiseo, Giusy
    Giordano, Cesira
    Leonildi, Alessandro
    Menichini, Melissa
    Vecchione, Alessandra
    Pistello, Mauro
    Guarracino, Fabio
    Ghiadoni, Lorenzo
    Forfori, Francesco
    Barnini, Simona
    Menichetti, Francesco
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (04) : 1078 - 1084
  • [7] Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study
    Garcia-Vidal, Carolina
    Sanjuan, Gemma
    Moreno-Garcia, Estela
    Puerta-Alcalde, Pedro
    Garcia-Pouton, Nicole
    Chumbita, Mariana
    Fernandez-Pittol, Mariana
    Pitart, Cristina
    Inciarte, Alexy
    Bodro, Marta
    Morata, Laura
    Ambrosioni, Juan
    Grafia, Ignacio
    Meira, Fernanda
    Macaya, Irene
    Cardozo, Celia
    Casals, Climent
    Tellez, Adrian
    Castro, Pedro
    Marco, Francesc
    Garcia, Felipe
    Mensa, Josep
    Martinez, Jose Antonio
    Soriano, Alex
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (01) : 83 - 88
  • [8] Smoking and COVID-19: Adding Fuel to the Flame
    Kashyap, Vivek K.
    Dhasmana, Anupam
    Massey, Andrew
    Kotnala, Sudhir
    Zafar, Nadeem
    Jaggi, Meena
    Yallapu, Murali M.
    Chauhan, Subhash C.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 22
  • [9] Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2
    Manna, Sounik
    Baindara, Piyush
    Mandal, Santi M.
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (10) : 1397 - 1404
  • [10] Secondary Bacterial Infections in Patients With Viral Pneumonia
    Manohar, Prasanth
    Loh, Belinda
    Nachimuthu, Ramesh
    Hua, Xiaoting
    Welburn, Susan C.
    Leptihn, Sebastian
    [J]. FRONTIERS IN MEDICINE, 2020, 7